Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDThermo Fisher Scientific Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 15 | $5.03 | $5.31 | $5.10 |
| Q2 2025 | 14 | $5.16 | $5.32 | $5.23 |
| Q3 2025 | 15 | $5.44 | $5.64 | $5.50 |
| Q4 2025 | 15 | $6.39 | $6.50 | $6.44 |
| Q1 2026 | 11 | $5.41 | $5.87 | $5.59 |
| Q2 2026 | 4 | $5.79 | $5.97 | $5.88 |
| Q3 2026 | 4 | $6.08 | $6.27 | $6.17 |
| Q4 2026 | 7 | $6.85 | $7.06 | $6.96 |
| Q1 2027 | 4 | $6.01 | $6.19 | $6.10 |
| Q2 2027 | 4 | $6.40 | $6.60 | $6.50 |
| Q3 2027 | 5 | $6.58 | $6.79 | $6.68 |
| Q4 2027 | 8 | $7.47 | $7.70 | $7.59 |
Thermo Fisher Scientific Inc. Earnings Date And Information
Thermo Fisher Scientific Inc. last posted its earnings results on Wednesday, October 22nd, 2025. The company reported $5.79 earnings per share for the quarter, topping analysts' consensus estimates of $5.5 by $0.29. The company had revenue of 11.12 B for the quarter and had revenue of 42.88 B for the year. Thermo Fisher Scientific Inc. has generated $17 earnings per share over the last year ($16.53 diluted earnings per share) and currently has a price-to-earnings ratio of 32.61. Thermo Fisher Scientific Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 22nd, 2025 based on prior year's report dates.
Thermo Fisher Scientific Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/31/2025 | Q3 2025 | N/A | $4.28 | N/A | $10.92 B | $11.12 B |
| 08/01/2025 | Q2 2025 | N/A | $4.28 | N/A | N/A | $10.86 B |
| 05/02/2025 | Q1 2025 | N/A | $3.99 | N/A | N/A | $10.36 B |
| 02/20/2025 | Q4 2024 | N/A | $4.79 | N/A | N/A | $11.40 B |
| 11/01/2024 | Q3 2024 | N/A | $4.27 | N/A | N/A | $10.60 B |
| 08/02/2024 | Q2 2024 | N/A | $4.05 | N/A | N/A | $10.54 B |
| 05/03/2024 | Q1 2024 | N/A | $3.48 | N/A | N/A | $10.35 B |
| 02/22/2024 | Q4 2023 | N/A | $4.21 | N/A | N/A | $10.89 B |
| 11/03/2023 | Q3 2023 | N/A | $4.44 | N/A | N/A | $10.57 B |
| 08/04/2023 | Q2 2023 | N/A | $3.53 | N/A | N/A | $10.69 B |
| 05/05/2023 | Q1 2023 | N/A | $3.34 | N/A | N/A | $10.71 B |
| 02/23/2023 | Q4 2022 | N/A | $4.03 | N/A | N/A | $11.45 B |
| 11/04/2022 | Q3 2022 | N/A | $3.81 | N/A | N/A | $10.68 B |
| 08/05/2022 | Q2 2022 | N/A | $4.24 | N/A | N/A | $10.97 B |
| 05/06/2022 | Q1 2022 | N/A | $5.65 | N/A | N/A | $11.82 B |
| 02/24/2022 | Q4 2021 | N/A | $4.20 | N/A | N/A | $10.70 B |
| 11/04/2021 | Q3 2021 | N/A | $4.83 | N/A | N/A | $9.33 B |
| 08/06/2021 | Q2 2021 | N/A | $4.65 | N/A | N/A | $9.27 B |
| 05/07/2021 | Q1 2021 | N/A | $5.93 | N/A | N/A | $9.91 B |
| 02/24/2021 | Q4 2020 | N/A | $6.30 | N/A | N/A | $10.55 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Thermo Fisher Scientific Inc. Earnings: FAQ's
Thermo Fisher Scientific Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 22nd, 2025 based offlast year's report dates.
In the previous quarter, Thermo Fisher Scientific Inc. (:TMO) reported $5.79 earnings per share (EPS) to beat the analysts' consensus estimate of $5.5 by $0.29.
The conference call for Thermo Fisher Scientific Inc.'s latest earnings report can be listened to online.
The conference call transcript for Thermo Fisher Scientific Inc.'s latest earnings report can be read online.
Thermo Fisher Scientific Inc. (:TMO) has a recorded annual revenue of $42.88 B.
Thermo Fisher Scientific Inc. (:TMO) has a recorded net income of $6.34 B.Thermo Fisher Scientific Inc. has generated $16.58 earnings per share over the last four quarters.
Thermo Fisher Scientific Inc. (:TMO) has a price-to-earnings ratio of 32.61 and price/earnings-to-growth ratio is 565.13.